Select the name of the type of clinical care program you would like more information about …

Example: ‘B’ for Bladder Cancer

Cancer Treatment A-Z

Skip to content. | Skip to navigation

Personal tools

Navigation

You are here: Home
197 items matching your search terms.
Filter the results.
Item type














New items since



Sort by relevance · date (newest first) · alphabetically
PSA test discussed, Brewer quoted
by Mary Ruth published May 22, 2012 last modified May 22, 2012 12:36 PM — filed under: , ,
Located in News / 2012 News
BCBSNC Names Dr. Lisa Carey to Board of Trustees
by Mary Ruth published May 24, 2012 last modified Jun 04, 2012 10:54 AM — filed under: ,
CHAPEL HILL, N.C. – Blue Cross and Blue Shield of North Carolina (BCBSNC) has announced Dr. Lisa Carey, Medical Director of the University of North Carolina at Chapel Hill (UNC) Breast Center and Associate Director of UNC Lineberger Comprehensive Cancer Center, as the newest member of its board of trustees.
Located in News / 2012 News
N.C. Children's Hospital achieves high rankings in several specialties including cancer
by Mary Ruth published Jun 05, 2012 last modified Jun 15, 2012 12:15 PM — filed under: ,
Congratulations to the N.C. Children’s Hospital for receiving top rankings in 10 out of 10 clinical categories in U.S. News & World Report’s 2012-13 “America’s Best Children’s Hospitals” list. The N.C. Children’s Hospital is ranked 26th in cancer.
Located in News / 2012 News
Science, surgery, and start-ups - in depth with Dr. Nancy DeMore
by Mary Ruth published Jun 04, 2012 last modified Jun 06, 2012 11:10 AM — filed under: ,
UNC surgeon-scientist Dr. Nancy DeMore says, “As a physician, I’m acutely aware of how much more we need to learn about breast cancer and how urgently we need better therapies. It really gives me hope to be in the lab and to know that I’m working towards something that may make things better for patients.”
Located in News / 2012 News
UNC Lineberger member Kurt Ribisl co-authors study assessing online alcohol sales to minors
by Mary Ruth published Jun 07, 2012 last modified Jun 07, 2012 10:16 AM — filed under: ,
Kurt Ribisl, PhD, is co-author of the article “Internet Alcohol Sales to Minors” published online ahead of print in the May 2012 issue of the Archives of Pediatrics & Adolescent Medicine.
Located in News / 2012 News
UNC Lineberger member James Evans quoted in Nature
by Mary Ruth published Jun 07, 2012 last modified Jun 07, 2012 11:06 AM — filed under: , ,
James P. Evans, MD, PhD, Bryson Distinguished Professor of Genetics and Medicine, is quoted in an article discussing the fetal genome and the possibility of clinic procedures being introduced in the next couple of years.
Located in News / 2012 News
Mayer appointed to term on Cancer Survivorship Committee
by Mary Ruth published Jun 08, 2012 last modified Jun 08, 2012 02:44 PM — filed under: ,
Deborah Mayer, PhD, RN, AOCN, FAAN, associate professor in the UNC School of Nursing, has been appointed to a three-year term on the Cancer Survivorship Committee of the American Society of Clinical Oncology.
Located in News / 2012 News
Bae-Jump receives grant to study impact of obesity on ovarian cancer
by Mary Ruth published Jun 06, 2012 last modified Jun 11, 2012 12:12 PM — filed under: , ,
Victoria Bae-Jump, MD, PhD, has received a two-year $200,000 grant from the Department of Defense, to study “Preclinical and Clinical Investigations of the Impact of Obesity on Ovarian Cancer Pathogenesis.”
Located in News / 2012 News
Jennifer Bowman named Hometown Hero for June 11
by Mary Ruth published Jun 11, 2012 last modified Jun 12, 2012 09:25 AM — filed under: ,
WCHL named Jennifer Bowman a Hometown Hero for June 11, 2012. Each weekday the station selects a Hometown Hero who goes “over and above the call of duty,” exemplifying excellent service and dedication to others in the community.
Located in News / 2012 News
Combination therapy for triple-negative breast cancer disappointing
by Mary Ruth published Jun 12, 2012 last modified Jun 12, 2012 09:31 AM — filed under: , ,
CHAPEL HILL, N.C. – A recent clinical trial testing a combination therapy for basal-like (also known as triple-negative) breast cancer demonstrates that a combination of two drugs with promising preclinical results is not as effective as researchers had hoped.
Located in News / 2012 News